- Home
- STRM vs CLRB Comparison
STRM vs CLRB Comparison
Compare STRM & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRM
- CLRB
- Stock Information
- Founded
- STRM 1989
- CLRB 2002
- Country
- STRM United States
- CLRB United States
- Employees
- STRM N/A
- CLRB 11
- Industry
- STRM EDP Services
- CLRB Biotechnology: Pharmaceutical Preparations
- Sector
- STRM Technology
- CLRB Health Care
- Exchange
- STRM Nasdaq
- CLRB Nasdaq
- Market Cap
- STRM 15.4M
- CLRB 12.5M
- IPO Year
- STRM 1996
- CLRB N/A
- Fundamental
- Price
- STRM $2.59
- CLRB $0.25
- Analyst Decision
- STRM
- CLRB Hold
- Analyst Count
- STRM 0
- CLRB 1
- Target Price
- STRM N/A
- CLRB N/A
- AVG Volume (30 Days)
- STRM 5.9K
- CLRB 615.4K
- Earning Date
- STRM 06-10-2025
- CLRB 05-13-2025
- Dividend Yield
- STRM N/A
- CLRB N/A
- EPS Growth
- STRM N/A
- CLRB N/A
- EPS
- STRM N/A
- CLRB N/A
- Revenue
- STRM $17,901,000.00
- CLRB N/A
- Revenue This Year
- STRM $18.64
- CLRB N/A
- Revenue Next Year
- STRM N/A
- CLRB N/A
- P/E Ratio
- STRM N/A
- CLRB N/A
- Revenue Growth
- STRM N/A
- CLRB N/A
- 52 Week Low
- STRM $1.82
- CLRB $0.22
- 52 Week High
- STRM $9.75
- CLRB $3.49
- Technical
- Relative Strength Index (RSI)
- STRM 44.37
- CLRB 42.33
- Support Level
- STRM $2.30
- CLRB $0.24
- Resistance Level
- STRM $3.40
- CLRB $0.26
- Average True Range (ATR)
- STRM 0.27
- CLRB 0.02
- MACD
- STRM 0.01
- CLRB -0.00
- Stochastic Oscillator
- STRM 32.32
- CLRB 21.37
About STRM Streamline Health Solutions Inc.
Streamline Health Solutions Inc provides transformational data-driven solutions for healthcare organizations. It provides computer software-based solutions through its looking glass platform. Its solutions include coding and CDI, coding audit, and financial management solutions. It offers various services, such as custom integration services, training services, electronic image conversion and database monitoring services. It sells its solutions and services in North America to hospitals and health systems, including physician practices, through its direct sales force and its reseller partnerships.
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.